Ibuprofen does not prevent postbronchoscopy fever in children undergoing broncho-alveolar lavage.
bronchoscopy
children
fever
ibuprofen
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
27
05
2020
accepted:
27
07
2020
pubmed:
30
7
2020
medline:
2
3
2021
entrez:
30
7
2020
Statut:
ppublish
Résumé
Fiber-optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB). To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB. Children presenting for elective FOB and broncho-alveolar lavage (BAL) were randomized, in a double-blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever. Sixty-one children were included in the final analysis. Thirty-one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35). FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti-inflammatory drug ibuprofen administered before a FOB does not prevent FPB.
Sections du résumé
BACKGROUND
Fiber-optic bronchoscopy (FOB) of the lower airways is a routine examination performed for investigating varying respiratory complaints in children. A common side effect is a transient high fever on the day of the FOB. Such episodes are usually unrelated to an infectious process but may cause clinical uncertainty and parental anxiety. We have previously shown that a single dose of systemic dexamethasone significantly reduces the rate of fever postbronchoscopy (FPB).
RESEARCH QUESTION
To prospectively analyze the effect of a prophylactic dose of ibuprofen upon the FPB.
STUDY DESIGN AND METHODS
Children presenting for elective FOB and broncho-alveolar lavage (BAL) were randomized, in a double-blind fashion, to receive a single dose of ibuprofen syrup 10 mg/kg or placebo prior to the procedure. Parents were contacted the next day to record the presence or absence of fever.
RESULTS
Sixty-one children were included in the final analysis. Thirty-one children were in the treatment group and 30 in the placebo group. FPB occurred in 40 children (65%). There was no difference in the rate of FPB between placebo (63%) and treatment (67%) groups (P = .717). Fifty (82%) children had a positive BAL culture. Among them, 38 had FPB (76%) compared with only 2 of 11 (18%) of those with negative culture (P = .00026, relative risk 4.18). About 80% of positive cultures grew Haemophilus influenza. There was no significant difference between the number of BALs with a positive culture between the treatment and placebo groups (87% vs 77%, P = .35).
CONCLUSION
FPB occurs in around twothirds of children when BAL is performed. Fever occurred significantly more frequently when BAL culture is positive. A single standard dose of the nonsteroidal anti-inflammatory drug ibuprofen administered before a FOB does not prevent FPB.
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Ibuprofen
WK2XYI10QM
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
2737-2741Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Schramm D, Yu Y, Wiemers A, et al. Pediatric flexible and rigid bronchoscopy in European centers-availability and current practice. Pediatr Pulmonol. 2017;52:1502-1508.
Carlens J, Fuge J, Price T, et al. Complications and risk factors in pediatric bronchoscopy in a tertiary pediatric respiratory center. Pediatr Pulmonol. 2018;53:619-627.
Fonseca MT, Camargos PA, Abou Taam R, Le Bourgeois M, Scheinmann P, de Blic J. Incidence rate and factors related to post-bronchoalveolar lavage fever in children. Respiration. 2007;74:653-658.
Schellhase DE, Tamez JR, Menendez AA. High fever after flexible bronchoscopy and bronchoalveolar lavage in noncritically ill immunocompetent children. Pediatr Pulmonol. 1999;28:139-144.
Picard E, Schwartz S, Goldberg S, Glick T, Villa Y, Kerem E. A prospective study of fever and bacteremia after flexible fiberoptic bronchoscopy in children. Chest. 2000;117:573-577.
Um SW, Choi CM, Lee CT. Prospective analysis of clinical characteristics and risk factors of postbronchoscopy fever. Chest. 2004;125:945-952.
Kane RC, Cohen MH, Fossieck BE, Tvardzik AV. Absence of bacteremia after fiberoptic bronchoscopy. Am Rev Respir Dis. 1975;111:102-104.
Gillis S, Dann EJ, Berkman N, Koganox Y, Kramer MR. Fatal Haemophilus influenzae septicaemia following bronchoscopy in a splenectomized patient. Chest. 1993;104:1607-1609.
Picard E, Schlesinger Y, Goldberg S, Schwartz S, Kerem E. Fatal pneumococcal sepsis following flexible bronchoscopy in an immunocompromized. Pediatr Pulmonol. 1987;25:390-392.
Picard E, Goldberg S, Virgilis D, Schwartz S, Raveh D, Kerem E. A single dose of dexamethasone to prevent postbronchoscopy fever in children. Chest. 2007;131:201-205.
Merkus P, Janssens H, Pjinenburg M. Dexamethasone to prevent postbronchoscopy fever - letter to the editor. Chest. 2007;132:1413-1414.
Aronoff DM, Neilson EG. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med. 2001;111:304-315.
Standiford TJ, Kunkel SL, Strieter RM. Elevated serum levels of tumor necrosis factor-after bronchoscopy and bronchoalveolar lavage. Chest. 1991;99:1529-1530.
Krause A, Hohberg B, Heine F, John M, Burmester GR, Witt C. Cytokines derived from alveolar macrophages induce fever after bronchoscopy and bronchoalveolar lavage. Am J Respir Crit Care Med. 1997;155:1793-1797.
Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw Hill Medical; 2011:968.
De Benedictis FM, Bush A. Corticosteroids in Respiratory diseases in children. Am J Respir Crit Care Med. 2012;185:12-23.
Schimmer BP, Parker KL. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2007:1587-1612.